SCHEMBL22947692

SCHEMBL22947692

CS1(C)c2ccccc2-c2ccc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)cc21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.44
MEN1 O00255 8/20 0.42
KMT2A Q03164 8/20 0.42
MAPT P10636 5/20 0.42
ALDH1A1 P00352 5/20 0.42
HPGD P15428 4/20 0.42
NTSR1 P30989 1/20 0.39
ADORA2A P29274 3/20 0.38
ADORA1 P30542 3/20 0.38
ADORA3 P0DMS8 2/20 0.38
ADORA2B P29275 2/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
LMNA P02545 4/20 0.38
KDM4E B2RXH2 3/20 0.37
GLA P06280 1/20 0.37
POLB P06746 2/20 0.36
CHEK1 O14757 1/20 0.36
GPR35 Q9HC97 1/20 0.36
NPSR1 Q6W5P4 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22947473 0.98 L3MBTL1 (0.43) L3MBTL1MEN1KMT2AMAPTALDH1A1
SCHEMBL22949619 0.97 L3MBTL1 (0.47) L3MBTL1MEN1KMT2AMAPTALDH1A1
SCHEMBL22947495 0.95 L3MBTL1 (0.43) L3MBTL1MEN1KMT2AMAPTALDH1A1
SCHEMBL22947715 0.95 L3MBTL1 (0.43) L3MBTL1MEN1KMT2AMAPTALDH1A1
SCHEMBL22947683 0.93 SMN1; SMN2 (0.41) L3MBTL1MEN1KMT2AMAPTALDH1A1
SCHEMBL22949183 0.92 L3MBTL1 (0.41) L3MBTL1MEN1KMT2AMAPTALDH1A1
SCHEMBL22949685 0.91 L3MBTL1 (0.40) L3MBTL1MEN1KMT2AMAPTALDH1A1
SCHEMBL22949548 0.89 ALDH1A1 (0.44) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22947690 0.88 KDM4E (0.46) L3MBTL1MEN1KMT2AMAPTALDH1A1
SCHEMBL22947608 0.84 L3MBTL1 (0.40) L3MBTL1MEN1KMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210036245-A1 HETEROAROMATIC COMPOUNDS MERCK PATENT GMBH (DE) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210036245-A1 HETEROAROMATIC COMPOUNDS ETV6, FES, LEF1 L3MBTL1 3138/4885MEN1 2439/4885KMT2A 2115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.